Wegener's granulomatosis in north India. An analysis of eleven patients.
Eleven patients with Wegener's granulomatosis were seen at this Institute over a period of 20 years. There were six men and five women. The average age of presentation was 38.3 years, and the mean duration of symptoms was 10.5 months. Constitutional symptoms (82%), cough (82%), ocular symptoms (64%), arthralgias (55%), rhinorrhoea (55%), haemoptysis (45%), nasal granuloma (45%), otorrhoea (36%), sinusitis (36%), skin lesions (27%), and renal failure (27%) were the clinical manifestations encountered. All patients had an elevated ESR, and 55% had leucocytosis. Proteinuria and haematuria were observed in 64% and 55% respectively. Chest radiographs were abnormal in 82%. In four patients the disease had a fulminant course and the patients died before adequate treatment was given. Two patients received corticosteroids alone and have since been lost to follow up. Five (45%) received adequate cytotoxic therapy and have done well for 8-46 months (mean, 24.8 months) after diagnosis. Wegener's granulomatosis in India is apparently similar to that seen elsewhere, but the high incidence of tuberculosis interferes with early diagnosis and treatment.
Bambery
P
P
Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sakhuja
V
V
Gupta
A
A
Behera
D
D
Kaur
U
U
Bhusnurmath
S R
SR
Jindal
S K
SK
Malik
S K
SK
Deodhar
S D
SD
Chugh
K S
KS
D000293:Adolescent; D000328:Adult; D000368:Aged; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007194:India; D008297:Male; D008875:Middle Aged
D005938:Glucocorticoids; D003520:Cyclophosphamide